insights_auto
Why is EVGN down 4.09%?
Dive Deeperchevron_right
EVGN:NASDAQ
Evogene Ltd
$0.38
arrow_downward
-4.09%(-0.016) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVGN...
Open
$0.39
High
$0.39
Low
$0.37
Mkt. cap
6.90M
Avg. vol.
2.57M
Volume
106.04K
52-wk high
$1.49
52-wk low
$0.35
EPS
-$0.90
Beta
1.44
Shares outstanding
18.05M
No. of employees
52
Open
$0.39
High
$0.39
Low
$0.37
Mkt. cap
6.90M
Avg. vol.
2.57M
Volume
106.04K
52-wk high
$1.49
52-wk low
$0.35
EPS
-$0.90
Beta
1.44
Shares outstanding
18.05M
No. of employees
52
News stories
From web sources and news partners
ChartMill
·
1 day ago
Friday's session: top gainers and losers in the dow jones index
AOL.com
·
19 hours ago
If a Bear Market Is Coming in 2027, I'm Making This 1 Move Right Now
The Motley Fool
·
13 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
The Washington Post
·
1 day ago
How major US stock indexes fared Friday 10/9/2026
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd